U.S. Rule to Hike Drug Costs for Millions as Customs Crackdown Begins

Millions of Americans face higher drug costs as a new customs rule takes effect, impacting access to affordable medications from Canada.

Editorial Desk

October 8, 2026 One Min Read

POLICY WIRE — Washington, D.C. — A new U.S. customs rule set to take effect this month is expected to significantly increase the cost of prescription drugs for millions of Americans who rely on purchasing medications from Canadian pharmacies.

The rule suspends the de minimis exemption, which previously allowed low-value international shipments, including medications, to enter the U.S. duty-free. Starting October 22, these shipments will require additional documentation and a bond guarantee, making it more difficult and costly for individuals to obtain affordable medicines from abroad.

📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES

👉 READ BY CLICKING HERE

The change has drawn criticism from Democrats and some Republicans, who argue that it will disproportionately affect patients who depend on lower-cost drugs from Canada. Advocates warn that the rule could lead to steep price hikes for essential medications, with some prescriptions doubling in cost due to added fees and tariffs.

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.